PALB2 and small cell lung carcinoma: While inactivating (nonsense or essential splice-site) mutations of both TP53 and RB1 is associated with a significant fraction of SCLC cases38, whole exome screening of the SCLC patient carrying the PALB2 T413S mutation detected only an inactivating nonsense mutation in TP53 (Figure 5).